Top Markets
Coin of the day
Lattice Biologics Ltd. Lattice Biologics Ltd.

Lattice Biologics Ltd.

LBLTF
Kedudukan dalam Saham #41554
Lattice Biologics Ltd. is a biotechnology firm focused on developing,... Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as AmnioBoost and AmnioBlast. In addition, their product line features a broad range of allografts, encompassing traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix varieties. These versatile products serve numerous critical medical applications, from enhancing spinal fusion and aiding breast reconstruction post-mastectomy to promoting bone regeneration in foot and ankle surgeries and fostering skull healing after neurosurgery. They also play a role in improving wound repair for burn victims, facilitating hernia repair, addressing subchondral bone defects in knee and other joint surgeries, and supporting various sports medicine procedures, including anterior and posterior cruciate ligament repairs. The company's headquarters are located in Belgrade, Montana.
Harga Saham
$0.0001
Disegerakkan terakhir: 2026-08-11
Modal Pasaran
$16.55K
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan Lattice Biologics Ltd. (LBLTF)

Kategori

EPS untuk Lattice Biologics Ltd. (LBLTF)
EPS setakat 2026 TTM: 0
Menurut laporan kewangan terkini dan harga saham Lattice Biologics Ltd., EPS semasa syarikat (TTM) adalah 0. Pada akhir tahun 2026, syarikat mempunyai EPS sebanyak 0 sama dengan EPS tahun 2026 iaitu 0.
Sejarah EPS untuk Lattice Biologics Ltd. dari 2026 hingga 2026
EPS pada akhir setiap tahun
Tahun EPS Ubah
Tidak cukup data untuk tarikh yang disediakan.
EPS untuk syarikat atau pesaing yang serupa